The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
Marijuana ointments as cancer treatments remain a distant prospect.
The Scientist
Most Recent
Researchers suspect the source of the toxins may be some of the state’s 50,000 or so marijuana farms.
And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.
Around 40 percent of children with an uncommon disorder had 50 percent fewer seizures while taking the marijuana derivative.
In young mice, THC had the opposite effect.
Academics partner with a biotech firm to investigate cannabinoids and develop potential therapeutics.
US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.
A new report summarizes what we know about the impacts of marijuana use, as more states have legalized the drug for both medical and recreational purposes.
The US Drug Enforcement Agency continues to classify marijuana as a Schedule 1 drug, however, perpetuating challenges for researchers.
A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder.
Popular Now
-
The Nutshell Salk Institute Suspends Cancer Scientist Inder Verma -
The Nutshell Long-Term Study Reveals Flip in Plant Responses to Carbon Dioxide The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
-
The Nutshell Jim Bridenstine Confirmed to Lead NASA The US Senate narrowly approved the politician, who does not have a science background.
-
Daily News RNA Injection Restores Hearing in Guinea Pigs Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
Current Issue
© 1986-2018 The Scientist
